Pain After Preoperative UltraSound Guided Hip Injections for Total Hip Arthroplasty (PUSH)

Completed · Not applicable

Conditions studied: Total Hip Replacement, Arthroplasty

In brief

The purpose of the study is to assess the accuracy of Butterfly IQ ultrasound for intra-articular hip injections, and to see if an injection given intra-articular before incision provides any benefit in preemptive pain relief or blood loss reduction.

Key facts

Study ID

NCT04219098

Run by

Anne Arundel Health System Research Institute

People needed

75

Starts

2020-02-01

Expected to finish

2021-08-30

Last updated by the study team

2024-08-07

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects meeting all of the following specific criteria will be considered for participation in the study:
• Subject is between 18-80 years of age.
• Subject is a suitable candidate for total hip replacement.
• Subject scheduled for surgery with the Butterfly IQ trained PA providing surgical assistance
• Subject has given voluntary, written informed consent to participate in this clinical investigation and has authorized the transfer of his/her information to AAHS RI
• Subject, in the opinion of the Clinical Investigator, is able to understand this clinical investigation and is willing and able to perform all study procedure and follow-up visits and co-operate with investigational procedures.
• Subject must be comfortable with speaking, reading, and understanding questions in English and providing an appropriate response.

You may not qualify if…

• Subjects will be excluded from participation in the study if they meet any of the following criteria:
• Subject is a woman who is pregnant or lactating
• Subject from the vulnerable groups: prisoners, adults unable to consent, children, non-English speaking, illiterate, and/or visually impaired)
• Subject who is not comfortable with speaking, reading, and understanding questions in English and providing an appropriate response.
• Subject who cannot or refuses to give voluntary, written informed consent to participate in this clinical trial
• Subject has contraindications for any of the following: Ropivicaine, Epinephrine or Methylene Blue
• Previous hip surgery
• History of infection in hip
• Morbid obesity defined as BMI>40

Where it is running

• Anne Arundel Medical Center — Annapolis, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.